Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Bestqool Pro Series Redefines the Standard of Red Light Therapy Devices: Cutting-Edge Technology Undergone the Third-party Laboratory Diagnostic Testing 2024-07-09 21:00
Clinion Applauded by Frost & Sullivan for Enabling Interoperability and Continuity in Clinical Trials Management with its eClinical Solutions 2024-07-09 21:00
Pulnovo Medical Announces Joining PHA's (Pulmonary Hypertension Association) Corporate Committee 2024-07-09 20:00
Porton J-STAR and Enabling Technologies Consortium Collaboration on Co-processing Platform Technology Development 2024-07-08 22:00
Goodix Launches Its Latest Automotive-Grade Bluetooth LE SoC and CGM Solutions at electronica China 2024 2024-07-08 22:00
Alteogen Receives Ministry of Food and Drug Safety (MFDS) Approval for Tergase® 2024-07-08 21:00
GEN Z TAKING PROACTIVE STEPS TO ADDRESS MENTAL HEALTH ISSUES 2024-07-08 19:41
Cambrex to Expand Stability Storage Business with New Facility in Durham, North Carolina 2024-07-08 18:00
DP Technology Announces Nomination of Development Candidate, a CNS Penetrable Lp-PLA2 Inhibitor for Alzheimer's Disease 2024-07-08 17:23
MGI Tech Partners with Australian Research Council Training Centre CEAStAR to Lead Innovation in Antimicrobial Resistance Solutions 2024-07-08 17:14
DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Lp-PLA2 Inhibitor for DR and DME 2024-07-08 17:00
Immorna Biotherapeutics Receives U.S. FDA IND Clearance to Conduct Phase 1/2 Study of JCXH-211 IV as Monotherapy and in Combination with Checkpoint Inhibitor in Patients with Advanced Solid Tumors 2024-07-08 16:28
Sirnaomics Announces Interim Results for Successful Completion of the Second Cohort of Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Therapeutics 2024-07-08 14:30
Parents: Discover the Three Essential Pillars of Childcare for Your Child's Optimal Development 2024-07-08 14:13
BioCity announces its endothelin receptor A selective antagonist SC0062 met the primary endpoint in IgA nephropathy in 2-SUCCEED trial: a randomized, double-blind, placebo-controlled Phase 2 trial 2024-07-08 13:41
Fosun International Ranks Among China's Top 100 ESG Listed Companies, Topping the Composite Industry as the ESG Leader 2024-07-08 10:42
Resounding Success! Hi & Fi Asia-China 2024 Hits Historic Highs 2024-07-08 10:30
SWISS REJU Wins Highly Coveted "HK01 Good Living Award", Applauded as Top Beauty Brand in Hong Kong 2024-07-08 10:00
Olverembatinib Approved for Commercialization in Macau China 2024-07-08 08:55
Innovent Launches Environmental, Social and Governance (ESG) Website to Advance Sustainability and Corporate Responsibility 2024-07-08 08:00
1 60 61 62 63 64 1618